Nu Skin Q3 Revenue Falls 14.6% to $311M, Adjusted EPS Drops to $0.10
NUS is trading near its 52-week low of $4.445 (1.9% above the low).
Summary
Q3 revenue came in at $311.0 million, down 14.6% year over year, with a 1.1% FX drag. The top line landed inside guidance, but profitability thinned sharply: gross margin fell to 65.0% from 70.5% and operating margin dropped to 1.6% (3.7% adjusted) from 5.9%. Adjusted EPS was $0.10 versus $0.34 a year ago, and the company posted a 3Q loss of $742,000. The customer base keeps shrinking — customers fell 18% to 609,469, paid affiliates 10% to 116,449 and sales leaders 13% to 26,995 — with every region down double digits except the small 'Nu Skin Other' line. Management guided Q4 revenue to $310-340 million, down 16% to 8%, and full-year revenue to $1.26-1.29 billion with adjusted EPS of $0.55-0.65. This follows the Q2 print that showed revenue down 17% and a large goodwill impairment; the decline is now a multi-quarter pattern rather than a one-off. The stock sits near its 52-week low of $4.445, so the market has already priced in a lot of bad news — the question is whether the Q4 sequential-growth claim holds.
At the time of this announcement, NUS was trading at $4.53 on NYSE in the Trade & Services sector, with a market capitalization of approximately $220.5M. The 52-week trading range was $4.45 to $11.67. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: BusinessWire.